David Collier

Nov 29, 2024 | nature.com | Martyn Smith |Cliona M. McHale |David Collier |Angel Nadal |Christopher Rhodes |Robert Sargis

AbstractMetabolism-disrupting agents (MDAs) are chemical, infectious or physical agents that increase the risk of metabolic disorders. Examples include pharmaceuticals, such as antidepressants, and environmental agents, such as bisphenol A. Various types of studies can provide evidence to identify MDAs, yet a systematic method is needed to integrate these data to help to identify such hazards.

Nov 11, 2023 | nejm.org | David Collier

Published November 11, 2023N Engl J Med 2023;389:2319-2330DOI: 10.1056/NEJMoa2310610 For permission requests, please contact NEJM Reprints at [email protected] NotesThis is the New England Journal of Medicine version of record, which includes all Journal editing and enhancements. The Author Accepted Manuscript, which is the author’s version after external peer review and before publication in the Journal, is available at PubMed Central.